Skip to content
Home/Companies/MedTech/Tissuemed

Tissuemed

MedTech·UK·Exited 2021·Held 7yr
Entry
2014
Hold
7yr
Exit
2021

Who owns Tissuemed?

Tissuemed was owned by Shackleton Ventures through Shackleton Ventures (Evergreen) (2006 vintage) from 2014 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-30

Shackleton Ventures
Investor
Shackleton Ventures
Shackleton Ventures (Evergreen) · 2006 · Evergreen

Key facts

HQUK
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from Shackleton Ventures (Evergreen)

Other portfolio companies in the same fund.

Dexam International
Dexam International
Active
ConsumerUK
Gorilla Technology Group
Gorilla Technology Group
Active
AI/MLUK
Ioniq Group
Ioniq Group
Active
FinancialsGermany· 2024
Alusid
Alusid
Active
ConstructionUK· 2023
Omnigen
Omnigen
Active
HealthTechUK· 2023
Varamis Rail
Varamis Rail
Active
LogisticsUK· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Tissuemed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Tissuemed?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Tissuemed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue